| FDA approves Vermillion's ovarian cancer test | | Print | |
| Written by Staff and Wire Reports | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Friday, 11 September 2009 16:43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
The new FDA-Approved Ovarian Cancer Test is based on an HDC Patented Technology developed and owned by Health Discovery Corporation (OTCBB: HDVY). HDVY’s patented technology played a pivotal role in identifying biomarkers in Vermillion's ovarian cancer test and HDVY prosecuted a patent infringement action against Vermillion’s predecessor company, Ciphergen Biosystems, Inc., which resulted in a $600,000 cash settlement in favor of Health Discovery Corporation and a grant of a limited license to Vermillion. BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read at the bottom of / About Us / Section Add this page to your favorite Social Bookmarking websites           
Set as favorite
Bookmark
Email this
Trackback(0)
Comments (16)
Danny
said:
|
The U.S. Food and Drug Administration on Friday said it has approved a blood test for detecting ovarian cancer in a pelvic mass that already is known to require surgery.
The test, called OVA1, helps patients and healthcare providers decide what type of surgery should be done and by whom, the FDA said in a statement.
TrackBack URI for this entry
Subscribe to this comment's feed|
... This stock still has PLENTY of room to grow, the first stock to be approved for ovarian cancer is serious news. The only question is.. can they stay alive. |
|
April Thomas
said:
|
... I agree, it would have been nice to know this was coming up. too little too late |
|
Nader
said:
|
... Suck it up & move on - Seriously!! Do your own due diligence and reap the benefits - How many of you would have invested in this company if Mike posted it??? KNOWING it was a Bankrupt company to begin with? Don't blame this site; blame yourselves or better yet thank this site for not recommending BK companies. BIOMEDREPORTS! Keep up the Great Work! |
|
Vex
said:
|
... I agree with Nader. Stop whining, people. Regarding VRMLQ; This thing still has room to grow IMO. The masses don't seem to have discovered this one yet, judging by Friday's (9/11) modest 1.7 M share volume. Also, notice the stock was at ~.06 until 3:00PM EST. Looks like a good buy after the morning profit-taking selloff. Should have a big day Monday. I'm too scared to jump in, but that's just what I think will happen. |
|
Dave
said:
|
... A 2500% plus return on this stock in about an hour . How could it be over looked , I never saw it on the upcoming FDA approvals. That is why I paid for this subscription , for Due Diligence , you don't know what your talking about, go suck an egg NADER , I spend 2 hours a day searching and deciding trade strategies. You know nothing !!! By the way I doubt if this company is BK anymore NADER, after Friday. We deserve better information ,why post this article hours later. Timing is everything in buying a stock ,because it can go down as fast as up.... to be continued... |
|
Nader
said:
|
... I stand corrected - YES one person would have jumped in when the company was bankrupt - Maybe you should jump in monday! And no, this doesn't take it out of Bankruptcy - but what do i know? i'm sucking an egg at the moment. |
|
Dave
said:
|
... Hey Nader The test was developed by Vermillion, Inc. (OTC: VRMLQ.PK), a molecular diagnostics company, in cooperation with Quest Diagnostics /quotes/comstock/13*!dgx/quotes/nls/dgx (DGX 54.22, -0.33, -0.60%) , the world's leading provider of cancer diagnostics. Quest Diagnostics, which is a long-time investor in research and development of the OVA1 technology, has exclusive rights to offer the test to the clinical reference laboratory market in the U.S. for three years. About Vermillion Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at www.vermillion.com. About Quest Diagnostics Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com. I know I would of made some serious money on this one , that my point , oh if I would known about this stock. Let's see if I invested 500.00 in this stock @ .05 which is about 10000 shares, and I get a 2600% increase in about a hour , that would be 12900.00 minus my original investment of 500.00 dollars = 12400.00 pre-tax of course. to be continued.... |
|
Nader
said:
|
... Dave :) I am with you - it would have been a great ride - I wish we were posted as well - but i don't blame BMR for not writing an article about a company who filed BK. 1 hr 2600% Remember TTNP/VNDN or HGSI with BMRs track record we will surely get a piece of this pie but at least for me i'm looking for the next one that comes. No hard feelings - we're in the same boat - just our responses might be different. |
|
Johnson
said:
|
... Hi All, Yes, I agree with all of you about being late informed of the stock... But it had been done. Don't you think we should focus in the more important point like "Does this stock has more room to growth, and how high can it goes?" in both short and long term. |
|
Kaptain Krunchy
said:
|
... Overall BIEL will get an 8000% return by December 2010, and this site recommended them when they where just .005, thanks BMR, love you guys! |
|
Ravi Reddy
said:
|
... I suggest BMR do its job( keep a fully updated FDA calender) and leave the DD to us investors... |
|
Veronica Guerola
said:
|
... Having a paid service I expect to have access to ALL upcoming FDA dates. Let the investor complete the DD on a respective company to invest or not. I would have looked close at this company even if it was BK. Hindsight is 20/20, but I would have at LEAST put a few hundred dollars in this company - just as I did with HGSI. BMR - please keep your paid users up to date - or at least publish a link to another calendar, which will keep your readers in the know. Aaron |
|
Dave
said:
|
... I want to apologize to BioMeds for being angry and saying unfair comments about them ,I just wish I would of know about this stock ,it is very difficult to make money in the market due to reasons we all know.Thank You |
|
Ben Hopps
said:
|
... Holy WTF!..and now its at 8.45 Funny thing is, I had seen something about this company posted somewhere awhile back but I cant recall where. Would I have thrown 2-3k into it knowing it was about to go B/K..I will never know. But I probably would have, once I saw that it only had 4million shares out (if I went that far to research it). So, on to another related subject. Anyone know of any LOW float penny stocks with upcoming FDA approval dates? I looked at LLBO but didnt like that they have several billion shares out. I am truly astounded at what Vermillion did. I would be willing to pay 10g's a year if there were some company that offered every bit of info needed to find these type of companies. I will also say this...I made pretty good money this year but I have been absolutely baffeled by the way some stocks act after FDA approval. I hit home runs on my first 6 buys but then have been slowly getting killed on other approval stocks..GTCB, BDSI, SPPI, and a few others. WTF makes one company go up 20,000% on approval of a test (cant just be the low float can it?) and another company like SPPI (with only 48million float..still comparitively low) sink 30% on a great approval ? Is it manipulation? What the hell happened to BDSI? Sank like a rock after approval. What makes Vermillion so much better (20,000% better) than a company like SPPI? I know that Vermillion can probably come out of BK now, but after approval who would have guessed that the stock would hit almost 9$..what made them shoot up so high? So what? they got a test approved..but they need money to manufacture it, sell it, so on and so forth..even with the partnership with Quest. (Im sort of ranting I guess), but my frustration is not so much that I missed Vermillion, but Im more pissed that alot of companies that I made good approval calls on, went down, while one thats basically bankrupt goes up 20,000% in less than 3 weeks. I mean I didnt expect SPPI to go up 20,000% but I did expect it to at least double or triple and keep that support level. It hit 10$ for a day and then starting tanking and it has not stopped! I had 240g's in that. I didnt even have a CHANCE to sell at 10bucks, it went by that fast. Anyway, if anyone has few good penny stocks awaiting FDA approval by all means feel free to post here. Not really my thing (penny stocks) but there is obviously some money to be made in a few of these. And yes, I am aware of BIEL and made some decent money swing trading that, but until they update their pink sheets Im very wary of staying long with them. They have yet to say 100% how many shares they have out TODAY. They had 1 billion out a few months ago but they could have 4 billion today as far as anyones guess. |
|
Write comment
Sign Up For Phone Alerts
